awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36511158-A38D4869-8015-47D2-845F-3C1DF2C83A12
Q36511158-A38D4869-8015-47D2-845F-3C1DF2C83A12
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36511158-A38D4869-8015-47D2-845F-3C1DF2C83A12
Phase I and clinical pharmacology study of bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory/recurrent solid tumors.
P2860
Q36511158-A38D4869-8015-47D2-845F-3C1DF2C83A12
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36511158-A38D4869-8015-47D2-845F-3C1DF2C83A12
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7ad31d03a98e6719e996c001fd01c78b98c946c2
P2860
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.